Free Trial

Milestone Pharmaceuticals (MIST) Institutional Ownership

Milestone Pharmaceuticals logo
$0.76 +0.05 (+6.73%)
Closing price 04:00 PM Eastern
Extended Trading
$0.75 -0.01 (-1.18%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Milestone Pharmaceuticals (NASDAQ:MIST)

Current
Institutional Ownership
Percentage
86.18%
Number of
Institutional Buyers
(last 12 months)
35
Total
Institutional Inflows
(last 12 months)
$30.15M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$13.48M
Get MIST Insider Trade Alerts

Want to know when executives and insiders are buying or selling Milestone Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MIST Institutional Buying and Selling by Quarter

Milestone Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/8/2026Valeo Financial Advisors LLC146,699$127K0.0%+12.2%0.118%
10/6/2026RVW Wealth LLC1,148,260$994K0.1%N/A0.922%
9/9/2026Squarepoint Ops LLC231,824$311K0.0%-31.2%0.186%
8/26/2026HighTower Advisors LLC20,000$27K0.0%+100.0%0.016%
8/23/2026Guardian Wealth Advisors LLC NC339,450$455K0.0%+21.1%0.273%
8/17/2026Seven Fleet Capital Management LP270,233$362K0.1%-18.9%0.217%
8/14/2026ADAR1 Capital Management LLC100,000$134K0.0%N/A0.080%
8/11/2026TRU Independence Asset Management 2 LLC150,000$201K0.1%N/A0.120%
7/9/2026Bay Rivers Group46,633$62K0.0%+55.9%0.037%
6/4/2026Seven Fleet Capital Management LP333,333$397K0.1%N/A0.268%
5/14/2026Renaissance Technologies LLC129,705$154K0.0%N/A0.108%
5/1/2026Welch & Forbes LLC25,000$30K0.0%N/A0.021%
4/16/2026SG Americas Securities LLC42,512$51K0.0%-56.3%0.036%
2/24/2026TRU Independence Asset Management 2 LLC100,000$202K0.1%N/A0.117%
2/19/2026Invesco Ltd.21,893$44K0.0%N/A0.026%
2/18/2026XTX Topco Ltd171,960$347K0.0%-8.2%0.202%
2/18/2026Engineers Gate Manager LP59,053$119K0.0%N/A0.069%
2/17/2026ADAR1 Capital Management LLC100,100$202K0.0%N/A0.118%
2/17/2026Cetera Investment Advisers20,722$42K0.0%N/A0.024%
2/17/2026Adage Capital Partners GP L.L.C.2,810,037$5.68M0.0%-59.7%3.299%
2/17/2026Guardian Wealth Advisors LLC NC263,200$532K0.0%+25.2%0.309%
2/17/2026Graham Capital Management L.P.133,620$270K0.0%N/A0.157%
2/16/2026Squarepoint Ops LLC249,344$504K0.0%N/A0.293%
2/16/2026Aptus Capital Advisors LLC263,200$532K0.0%+25.2%0.309%
2/13/2026Marshall Wace LLP1,656,821$3.35M0.0%+289.8%1.945%
2/11/2026LPL Financial LLC142,463$288K0.0%+49.5%0.167%
2/11/2026Propel Bio Management LLC4,118,321$8.32M7.1%-19.6%4.835%
2/9/2026Eaton Financial Holdings Company LLC12,750$26K0.0%N/A0.015%
2/9/2026Simplify Asset Management Inc.1,506,405$3.04M0.0%-46.8%1.769%
2/4/2026Strategic Family Wealth Counselors L.L.C.12,675$25K0.0%N/A0.015%
1/20/2026October Effect Ltd52,100$105K0.1%N/A0.061%
1/9/2026SG Americas Securities LLC97,375$197K0.0%N/A0.114%
1/7/2026Bay Rivers Group28,861$58K0.0%+72.9%0.034%
11/17/2025Millennium Management LLC401,559$803K0.0%N/A0.471%
11/17/2025Boxer Capital Management LLC666,666$1.33M0.4%N/A0.783%
11/17/2025Bank of America Corp DE16,052$32K0.0%+200,550.0%0.019%
11/14/2025Raymond James Financial Inc.26,600$53K0.0%-38.5%0.031%
11/14/2025Orbimed Advisors LLC3,221,828$6.44M0.2%N/A3.791%
11/14/2025Two Sigma Investments LP666,551$1.33M0.0%N/A0.784%
11/13/2025Pathstone Holdings LLC1,000,000$2M0.0%N/A1.177%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
11/13/2025UBS Group AG397,534$795K0.0%+23.2%0.468%
11/12/2025Aptus Capital Advisors LLC210,200$420K0.0%N/A0.247%
11/12/2025Propel Bio Management LLC5,124,890$10.25M10.3%+186.1%6.030%
11/7/2025GSA Capital Partners LLP78,747$157K0.0%N/A0.093%
10/29/2025AMH Equity Ltd231,671$463K0.6%N/A0.273%
10/21/2025Stephenson & Company Inc.20,000$40K0.0%N/A0.024%
10/20/2025Simplify Asset Management Inc.2,832,974$5.67M0.1%+186.2%3.333%
10/17/2025Sapient Capital LLC12,200$25K0.0%N/A0.014%
9/12/2025Valeo Financial Advisors LLC130,699$254K0.0%+553.5%0.154%
8/14/2025Raymond James Financial Inc.43,235$84K0.0%+30.1%0.081%
8/13/2025Walleye Capital LLC15,109$29K0.0%-83.6%0.028%
8/12/2025XTX Topco Ltd160,963$312K0.0%+209.5%0.301%
8/8/2025Creative Planning23,410$45K0.0%+74.6%0.044%
8/7/2025Simplify Asset Management Inc.990,000$1.92M0.1%+16.5%1.852%
7/22/2025Valeo Financial Advisors LLC130,699$254K0.0%+553.5%0.244%
7/9/2025Bay Rivers Group14,321$28K0.0%N/A0.027%
5/15/2025Propel Bio Management LLC1,451,557$1.16M1.3%N/A2.715%
5/14/2025Stonepine Capital Management LLC250,000$200K0.2%-50.0%0.468%
5/14/2025Walleye Capital LLC91,920$74K0.0%N/A0.172%
5/12/2025Alta Fundamental Advisers LLC1,427,479$1.14M0.7%-46.3%2.670%
5/8/2025XTX Topco Ltd52,004$42K0.0%+52.7%0.097%
2/19/2025Toronto Dominion Bank750,000$1.77M0.0%N/A1.406%
2/17/2025Stonepine Capital Management LLC500,000$1.18M1.0%-50.0%0.938%
2/17/2025Toronto Dominion Bank750,000$1.77M0.0%N/A1.406%
2/17/2025RTW Investments LP2,506,102$5.91M0.1%-23.0%4.699%
2/17/2025Millennium Management LLC2,703,259$6.38M0.0%-2.7%5.069%
2/17/2025Lion Point Capital LP1,025,806$2.42M12.7%-38.0%1.924%
2/17/2025Cubist Systematic Strategies LLC30,938$73K0.0%N/A0.058%
2/14/2025Boxer Capital Management LLC309,007$729K0.1%N/A0.579%
2/14/2025Nantahala Capital Management LLC1,445,264$3.41M0.1%-17.4%2.710%
2/14/2025Northern Trust Corp58,108$137K0.0%+112.6%0.109%
2/14/2025Two Sigma Securities LLC16,957$40K0.0%-26.7%0.032%
2/13/2025XTX Topco Ltd34,054$80K0.0%N/A0.064%
2/13/2025Envestnet Asset Management Inc.63,742$150K0.0%-9.7%0.120%
2/12/2025National Bank of Canada FI18,700$44K0.0%+163.4%0.035%
2/11/2025Virtu Financial LLC71,955$170K0.0%N/A0.135%
2/6/2025Jones Financial Companies Lllp11,000$26K0.0%+1,000.0%0.021%
1/24/2025Clear Creek Financial Management LLC10,500$25K0.0%-46.2%0.020%
11/25/2024PVG Asset Management Corp30,345$46K0.2%N/A0.057%
11/14/2024Stonepine Capital Management LLC999,790$1.52M1.0%-19.3%1.877%
11/5/2024BML Capital Management LLC1,136,091$1.73M1.0%+3.0%2.133%
11/1/2024Atria Investments Inc40,421$61K0.0%+44.4%0.076%
10/10/2024Valeo Financial Advisors LLC20,000$30K0.0%+100.0%0.038%
8/21/2024Stonepine Capital Management LLC1,239,199$1.64M1.5%-15.3%2.327%
8/15/2024Lion Point Capital LP2,340,207$3.09M5.6%+1.7%4.394%
8/15/2024Millennium Management LLC2,749,930$3.66M0.0%-3.7%5.163%
5/1/2024BNP Paribas Financial Markets16,900$30K0.0%+177.0%0.032%
4/26/2024Clear Creek Financial Management LLC25,000$45K0.0%-21.3%0.047%
4/23/2024BML Capital Management LLC606,145$1.09M0.7%+37.0%1.140%
1/30/2024BML Capital Management LLC442,352$739K0.6%+62.3%1.321%
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

9/21/2023Barclays PLC800,776$2.28M0.0%-5.4%2.399%
8/21/2023Affinity Asset Advisors LLC300,068$855K0.3%+50.5%0.899%
8/11/2023Beta Wealth Group Inc.14,127$40K0.0%N/A0.042%
8/3/2023Barclays PLC800,776$2.28M0.0%-5.4%2.400%
7/27/2023Virtu Financial LLC11,743$33K0.0%N/A0.035%
7/24/2023BML Capital Management LLC272,500$777K0.7%+23.9%0.817%
7/17/2023Clear Creek Financial Management LLC31,929$91K0.0%-11.1%0.096%
7/14/2023Valeo Financial Advisors LLC118,699$338K0.0%+4.4%0.356%
5/16/2023Alta Fundamental Advisers LLC897,961$3.54M1.5%+58.8%2.698%
5/15/2023Affinity Asset Advisors LLC199,382$786K0.3%+99.4%0.599%


MIST Institutional Ownership - Frequently Asked Questions

During the previous two years, 57 institutional investors and hedge funds held shares of Milestone Pharmaceuticals. The most heavily invested institutionals were Propel Bio Management LLC ($8.32M), Orbimed Advisors LLC ($6.44M), RTW Investments LP ($5.91M), Adage Capital Partners GP L.L.C. ($5.68M), Nantahala Capital Management LLC ($3.41M), Marshall Wace LLP ($3.35M), and Simplify Asset Management Inc. ($3.04M).Learn more on Milestone Pharmaceuticals' institutional investors.

86.18% of Milestone Pharmaceuticals' stock is owned by institutional investors. Learn more on MIST's institutional investor holdings.

Of the 48 institutional investors that purchased Milestone Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Propel Bio Management LLC ($4.78M), Orbimed Advisors LLC ($3.22M), Simplify Asset Management Inc. ($1.98M), Toronto Dominion Bank ($1.50M), Marshall Wace LLP ($1.23M), RVW Wealth LLC ($1.15M), and Pathstone Holdings LLC ($1M).

Institutional investors have bought a total of 16,021,637 shares in the last 24 months. This purchase volume represents approximately $30.15M in transactions.

The following institutional investors have sold Milestone Pharmaceuticals stock in the last 24 months: Adage Capital Partners GP L.L.C. ($4.17M), Simplify Asset Management Inc. ($1.33M), Propel Bio Management LLC ($1.01M), Squarepoint Ops LLC ($105.00K), Seven Fleet Capital Management LP ($63.10K), SG Americas Securities LLC ($54.86K), and Raymond James Financial Inc. ($16.64K).

Institutional investors have sold a total of 6,754,041 shares in the last 24 months. This volume of shares sold represents approximately $13.48M in transactions.



Institutional ownership data for NASDAQ:MIST is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 10/8/2026. New 13F filings are added each quarter as they're published.
From Our Partners